Renovaro Secures U.S. Patent for AI Drug Discovery Platform

Expanded IP Portfolio Enhances Data Harmonization and Predictive Analytics Capabilities for High-Growth Biomedical Markets Renovaro Inc., a clinical-stage precision medicine company, announced that its subsidiary BioSymetrics has received a Notice of Allowance from...

Download the Health Technology Insights Media Kit

Access audience insights, traffic stats, and partnership opportunities in one comprehensive media kit